-
Product Insights
NewNet Present Value Model: Merus NV’s Zenocutuzumab
Empower your strategies with our Net Present Value Model: Merus NV's Zenocutuzumab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Merus NV’s Petosemtamab
Empower your strategies with our Net Present Value Model: Merus NV's Petosemtamab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Simcere Pharmaceutical Group Ltd’s (Borneol + Edaravone)
Empower your strategies with our Net Present Value Model: Simcere Pharmaceutical Group Ltd's (Borneol + Edaravone) report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Pfizer Inc’s Sasanlimab
Empower your strategies with our Net Present Value Model: Pfizer Inc's Sasanlimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Meru County Wind Farm
Meru County Wind Farm is an onshore wind project located in Meru, Kenya. The project is owned and developed by Eurus Energy Holdings Corp; Meru County Investment and Development Corp; Windlab Pty Ltd. The project is currently under construction. Empower your strategies with our Meru County Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewNet Present Value Model: Merus NV’s MCLA-145
Empower your strategies with our Net Present Value Model: Merus NV's MCLA-145 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Meru County Solar PV Park
Meru County Solar PV Park is a solar PV project located in Meru, Kenya. The project is owned and developed by Eurus Energy Holdings Corp; Windlab Pty Ltd. The project is currently under construction. Empower your strategies with our Meru County Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Thematic Analysis
NewSharing Economy – Thematic Intelligence
Sharing Economy Thematic Intelligence Report Overview The sharing economy is an economic system in which private individuals share assets and services, either free or for a charge often using a community-based online platform. Individuals can share assets such as clothes and toys or services such as household skills and insurance. The sharing economy is based on ideas of community as the world grows ever more interconnected. As the sharing economy model reaches maturity, market players are harnessing technologies such as...
-
Thematic Analysis
NewState of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) – Thematic Intelligence
Although the pharmaceutical industry is often labeled as a recession-resistant, it is not immune to future challenges. Ongoing issues such as constraints on drug pricing and reimbursement (P&R), the evolving regulatory landscape, pressures to innovate, and pressures to address environmental, social, and governance (ESG) issues will continue to pose challenges for the pharmaceutical sector in the coming years. In this “The State of the Biopharmaceutical Industry” report, GlobalData examines the business environment and trends that are going to shape the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MCLA-129 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MCLA-129 in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MCLA-129 in Laryngeal Cancer Drug Details: MCLA-129 is under development for the...